Carmen Guillén‐Ponce

University of Verona — Italy

Medicine · Health Sciences

35h-index4.4kcitations360works9.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(84), Cancer Genomics and Diagnostics(63), Colorectal Cancer Treatments and Studies(55), Genetic factors in colorectal cancer(45), Frailty in Older Adults(32)

Publications356 total

Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis
Nature Communications·2025· 1 citedOpen Access
Wounded Glioma Syndrome: A Case Report With Narrative Review
Cureus·2025Open Access
The impact of early weight loss, systemic inflammation, and specialized nutritional supplements on prognosis in metastatic pancreatic cancer: Data from the PANTHEIA–SEOM study
Clinical Nutrition ESPEN·2025
2216MO VIRAGE trial: Randomized phase IIb, open-label, study of nab-paclitaxel and gemcitabine with/without intravenous VCN-01 in patients with metastatic pancreatic cancer (mPDAC)
Annals of Oncology·2025· 1 cited
Support Group Impressions of Hispanic-American Cancer Patients
American Journal of Clinical Oncology·2025
289P Prognostic significance of the systemic inflammation response index (SIRI) and nutritional status in metastatic pancreatic cancer: Results from the PANTHEIA–SEOM study
Annals of Oncology·2025Open Access
310P Cascade testing in families with hereditary pancreatic cancer
Annals of Oncology·2025Open Access
Experience of 25 patients treated with echoendoscopically implanted <sup>32</sup> P microparticles associated with chemotherapy in locally advanced pancreatic adenocarcinoma.
Journal of Clinical Oncology·2025
CARE-AI: Cancer assessment risk estimation using artificial intelligence.
Journal of Clinical Oncology·2025
Virtual Reality for Pain Management and Patient Satisfaction During Outpatient Hysteroscopy: A Randomised Controlled Trial
BJOG An International Journal of Obstetrics & Gynaecology·2025Open Access
4050 Induction or consolidation strategy in total neoadyuvant therapy?
Radiotherapy and Oncology·2025
3701 Unlocking Recovery: The Role of Dosimetry and Clinical Insights in Pelvic Floor Rehabilitation for Rectal Cancer
Radiotherapy and Oncology·2025
3051 Black Blood MRI: The secret weapon for contouring agreement
Radiotherapy and Oncology·2025
Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer
BMC Cancer·2025Open Access
African dust particles over the western Caribbean: Chemical characterization
Atmospheric Environment·2025· 1 citedOpen Access
Supplementary Table S5 from A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial
2025Open Access
Data from A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial
2025· 1 citedOpen Access
Supplementary Table S1 from A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial
2025Open Access
Supplementary Table S2 from A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial
2025Open Access
Supplementary Table S4 from A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial
2025Open Access
page 1 of 18Next →

Frequent Co-authors

Alfredo Carrato(11), Teresa Macarulla(7), Fernando Rivera(6), Javier Sastre(6), Enrique Aranda(6), José Montáns(5), Manuel Benavides(5), Javier Gállego(5), José Luís Soto(5), Jaime Feliú(5), Eduardo Díaz‐Rubio(5), M.J. Molina-Garrido(5), Julie Earl(4), Alfonso Sanjuánbenito(4), Eva Esteban Cardeñosa(4), Rafael López‐López(4), Margarita Reboredo(4), Pilar García‐Alfonso(4), María José Safont(4), Encarnación González‐Flores(4)